Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...

there’s nothing necessarily to say that companies won’t just re-price their drugs.” Dusetzina noted the Trump administration’s self-responsibility approach to lower drug costs is a shift ...

Currently, there is no generic version of Januvia. A person may speak with a doctor, healthcare professional, insurer, or pharmacist to determine the exact cost they will pay for Januvia.

That means for Januvia the price Medicare ... would want to make any changes." There are some ways the incoming Trump administration can hinder drug price negotiation, which conservatives oppose ...

That means for Januvia the price Medicare would pay would ... no reason why the administration would want to make any changes." There are some ways the Trump administration can hinder drug price ...

Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck faces ... to diversify its product lineup. There are rising concerns about the firm ...

Sales of its type 2 diabetes drug Januvia fell 27% from a year earlier ... The lung cancer market is one of the largest in oncology, so there is no doubt that the drug will be in demand.

Although there are other drugs ... based on factors specific to each drug, including its clinical value, and that of its competitors. Four drugs - Januvia, Novolog/Fiasp, Enbrel and Stelara ...

The discounts range from 79% for diabetes drug Januvia to 38% for blood cancer ... Services Chiquita Brooks-LaSure on Thursday if there was ever a moment when she thought the negotiations would ...